SN-38
<p>One-step mechanochemical preparation and prominent antitumor activity of SN-38 self-micelle solid dispersion</p>
12
Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations
14
The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2
15
Tumour regression and improved gastrointestinal tolerability from controlled release of SN 38 from novel polyoxazoline modified dendrimers
22
Genetic predisposition to the metabolism of irinotecan (CPT 11) Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN 38) in human liver microsomes
9
Pharmacokinetics and safety of DTS-108, a human oligopeptide bound to SN-38 with an esterase-sensitive cross-linker in patients with advanced malignancies: a Phase I study
10
Value of plasma SN-38 levels and DPD activity in irinotecan-based individualized chemotherapy for advanced colorectal cancer with heterozygous type UGT1A1*6 or UGT1A1*28
10
STA-8666, a novel HSP90 inhibitor/SN-38 drug conjugate, causes complete tumor regression in preclinical mouse models of pediatric sarcoma
13
In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes
14
The role of intestinal UDP-glucuronosyltransferases in 7-ethyl-10-hydroxy-camptothecin (SN-38) conjugation and toxicity
213
DETERMINATION OF SN 38 CONTENTS IN NANOCAPSULES BY CHROMATOGRAPHIC AND SPECTROPHOTOMETRIC METHODS
16
Antitumor efficacy of Folic Acid conjugated Polymeric Nanoparticles of SN-38 after oral delivery
10
A novel microfluidic liposomal formulation for the delivery of the SN-38 camptothecin: characterization and in vitro assessment of its cytotoxic effect on two tumor cell lines
20
Transcatheter hepatic therapy with irinotecan eluting beads (DEBIRI) for the treatment of colorectal liver metastases
284
Development and Validation for the Determination of Related Substance in Irinotecan HCL Formulation and its Stability Indicating Studies by RP - HPLC.
109
Bicarbonate Attenuates Irinotecan Induced Cytotoxicity through Regulation of Both Extracellular and Intracellular pHs in Intestine Cell Line
9
Human ABC transporter ABCG2/BCRP expression in chemoresistance: basic and clinical perspectives for molecular cancer therapeutics
12
sn metrizable spaces and related matters
9
Activity Measurement of Titanium Tin Alloys by Knudsen Effusion Method
5
Reactions in Electrodeposited Cu/Sn and Cu/Ni/Sn Nanoscale Multilayers for Interconnects
14